-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Regen BioPharma Inc annual/quarterly Earnings Per Share, Diluted history and growth rate from 2022 to 2024.
- Regen BioPharma Inc Earnings Per Share, Diluted for the quarter ending June 30, 2024 was -0.03 USD/shares, unchanged year-over-year.
- Regen BioPharma Inc annual Earnings Per Share, Diluted for 2024 was -0.21 USD/shares, a 172% decline from 2023.
- Regen BioPharma Inc annual Earnings Per Share, Diluted for 2023 was 0.29 USD/shares, a 59.1% decline from 2022.
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)